Catalyst is an exclusive early access program empowering developers of gene-edited therapies with unprecedented capabilities. As a Catalyst member, you will be among the first few to leverage the Broken String Biosciences INDUCE-seq® platform in your own lab, detecting on- and off-target edits at high resolution in just days. This first-of-its-kind early access opportunity to our on-demand offering accelerates your gene therapy development, reducing experimental times from months to days.